Con: All patients should not receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 1, 1999, Pages 101-104

  Hogue Jr , Charles W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial arrhythmias; Atrial fibrillation; Cardiac; Surgery

Indexed keywords

ANTIARRHYTHMIC AGENT;

HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; NOTE; POSTOPERATIVE COMPLICATION;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; HUMANS; POSTOPERATIVE COMPLICATIONS;

EID: 0033069476     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90183-0     Document Type: Article

References (40)

1. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation: Atrial fibrillation: Current understandings and research imperatives. J Am Coll Cardiol 22:1830-1834, 1993
2. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL: Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 56:539-549, 1993
3. Mathew JP, Parks R, Savino JS, et al: Atrial fibrillation following coronary artery bypass graft surgery. J Am Med Assoc 276:300-306, 1996
4. Aranki SF, Shaw DP, Adams DH, et al: Predictors of atrial fibrillation after coronary artery surgery: Current trends and impact on hospital resources. Circulation 94:390-397, 1996
5. Kowey PR, Dalessandro DA, Herbertdon R, et al: Effectiveness of digitalis with or without acebutolol in preventing atrial arrhythmias after coronary artery surgery. Am J Cardiol 79:1114-1117, 1997
6. Kalman JM, Munawar M, Howes LG, et al: Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 60:1709-1715, 1995
7. Steinberg JS, Zelenkofske S, Wong S-C, et al: Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 88:2618-2622, 1993
8. Cox JL: A perspective on postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 56:405-409, 1993
9. Cox JL, Canavan TE, Schuessler RB, et al: The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 101:406-426, 1991
10. Konings KTS, Kirchhof CJHJ, Smeets JRLM, et al: High-density mapping of electrically induced atrial fibrillation in humans. Circulation 89:1665-1680, 1994
11. Daoud EG, Strickberger SA, Man KC, et al: Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337:1785-1791, 1997
12. Kowey PR, Taylor JE, Rials SJ, Marinchak RA: Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 69:963-965, 1992
13. Andrews TC, Reimold SC, Berlin JA, Antman EM: Prevention of supraventricular arrhythmias after coronary artery bypass surgery: A meta-analysis of randomized control trials. Circulation 84:III236-III244, 1991 (suppl III)
14. Boudoulas H, Snyder GL, Lewis RP, et al: Safety and rationale for continuation of propranolol therapy during coronary bypass operation. Ann Thorac Surg 26:222-229, 1978
15. Suttorp MJ, Kingma JH, Gin MTJ, et al: Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg 100:921-926, 1990
16. Levy MN: Sympathetic-parasympathetic interactions in the heart. Circ Res 29:437-445, 1971
17. Lewis T, Drury AN, Bulger HA: Observations upon flutter and fibrillation, VII: The effect of vagal stimulation. Heart 8:141-169, 1921
18. Coumel P: Heart rate variability and the onset of tachyarrhythmias. G Ital Cardiol 22:647-654, 1992
19. Bailar JC: The promise and problems of meta-analysis. N Engl J Med 337:559-560, 1997
20. Hannes W, Fasol R, Zajonc H, et al: Diltiazem provides anti-ischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting. Eur J Cardiothorac Surg 7:239-245, 1993
21. Shenasa M, Kus T, Fromer M, et al: Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol 62:403-407, 1988
22. Laub GW, Janeira L, Muralidharan S, et al: Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting: A prospective, double-blind, randomized, placebo-controlled pilot study. Grit Care Med 21:1474-1478, 1993
23. Gold MR, O'Gara PT, Buckley MJ, DeSanctis RW: Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Am J Cardiol 78:975-979, 1996
24. Janssen J, Loomans L, Harink J, et al: Prevention and treatment of supraventricular tachycardia shortly after coronary bypass grafting: A randomized open trial. Angiology 37:601-609, 1986
25. Suttorp MJ, Kingma JH, Peels HOJ, et al: Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol 68:1163-1169, 1991
26. Hohnloser SH, Meinertz T, Dammbacher T, et al: Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: Results of a prospective, placebo-controlled study. Am Heart J 121:89-95, 1991
27. Butler J, Harriss DR, Sinclair M, Westaby S: Amiodarone prophylaxis for tachycardias after coronary artery surgery: A randomized, double-blind, placebo-controlled trial. Br Heart J 70:56-60, 1993
28. Faniel R, Schoenfeld P: Efficacy of IV amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients. Eur Heart J 4:180-185, 1983
29. Heijmerikas JA, Kirchhof CJ, Wellens HJJ: Atrial fibrillation following cardiac surgery in the elderly: Incidence, outcome of β-blocker use and effect on length of hospital length of stay. Circulation 96:1698, 1997 (abstr)
30. Mason JW: Amiodarone. N Engl J Med 316:455-466, 1987
31. Herndon JC, Cook AO, Ramsay MAE, et al: Postoperative unilateral pulmonary edema: Possible amiodarone pulmonary toxicity. Anesthesiology 76:308-312, 1992
32. Dimopoulou I, Marathias K, Daganou M, et al: Low-dose amiodarone-related complications after cardiac operations. J Thorac Cardiovasc Surg 114:31-37, 1997
33. Mangano DT, Layug EL, Wallace A, et al: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335:1713-1720, 1996
34. Ruskin JN: The Cardiac Arrhythmia Suppression Trial (CAST). N Engl J Med 321:386-388, 1989
35. Coplen SE, Antman EM, Berlin JA, et al: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials. Circulation 82:1106-1116, 1990
36. Soyka LF, Wirtz C, Spangenberg RB: Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol 65:74A-81A, 1990
37. Hohnloser SH, Klingenheben T, Singh BN: Amiodarone-associated proarrhythmic effects: A review with special reference to torsades de pointes tachycardia. Ann Intern Med 121:529-535, 1994
38. Newman MF, Wolman R, Kanchuger M, et al: Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Circulation 94:1174-1180, 1996 (suppl II)
39. Hammermeister KE, Burchfiel C, Johnson R, Grover FL: Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation 82:IV380-IV389, 1990 (suppl IV)
40. Pagé PL, Pym J: Atrial fibrillation following cardiac surgery. Can J Cardiol 12:40A-56A, 1996 (suppl A)